Skip to main content

Sponsored By

Lilly
Interview with the Innovators

Managing Abemaciclib Toxicity: Proactive Strategies for Improved Patient Outcomes

Videos
Heather Moore, PharmD, BCOP, CPP
Clinical Oncology Pharmacist, Breast Oncology
Duke Cancer Institute, Duke University Hospital
Durham, NC
In this fourth installment, Dr Moore shares strategies for optimizing abemaciclib treatment through dose escalation and proactive toxicity management. She emphasizes patient education on managing common side effects and highlights the importance of ongoing patient engagement through touchpoints and clear communication to ensure successful treatment outcomes.

Related Items